EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

The Role of Protein Aggregation in Pharmaceutical Drug Development

Dr. Amina Rauf

American Journal of Pharmaceutics · 2025-07-21 · 6 (2) · 1-14

DOI: 10.71465/ajph2737 ↗

At a glance

Journal article in American Journal of Pharmaceutics, published online on 2025-07-21. Written by Dr. Amina Rauf. The full text is freely available (open access, CC BY 4.0).

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Protein aggregation presents a significant challenge in the pharmaceutical drug development process, particularly for biologics and protein-based therapeutics. These aggregates can negatively impact drug efficacy, stability, and safety. This article explores the underlying mechanisms of protein aggregation, factors influencing it, and strategies to mitigate its effects during drug development. The study also discusses analytical methods for detecting aggregates and regulatory perspectives on aggregate control. Understanding and controlling protein aggregation is critical for enhancing drug formulation, storage, and delivery, ultimately leading to improved therapeutic outcomes.

Cite

APA

Rauf, D. A. (2025). The Role of Protein Aggregation in Pharmaceutical Drug Development. American Journal of Pharmaceutics, 6(2), 1-14. https://doi.org/10.71465/ajph2737

Vancouver

Rauf DA. The Role of Protein Aggregation in Pharmaceutical Drug Development. American Journal of Pharmaceutics. 2025;6(2):1-14. doi:10.71465/ajph2737

BibTeX
@article{Rauf2025,
  author = {Rauf, Dr. Amina},
  title = {The Role of Protein Aggregation in Pharmaceutical Drug Development},
  journal = {American Journal of Pharmaceutics},
  year = {2025},
  volume = {6},
  number = {2},
  pages = {1--14},
  doi = {10.71465/ajph2737}
}
Start for free →